BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19176489)

  • 1. Molecular characterization of feline COX-2 and expression in feline mammary carcinomas.
    Sayasith K; Sirois J; Doré M
    Vet Pathol; 2009 May; 46(3):423-9. PubMed ID: 19176489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.
    Millanta F; Citi S; Della Santa D; Porciani M; Poli A
    Breast Cancer Res Treat; 2006 Jul; 98(1):115-20. PubMed ID: 16538539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
    Millanta F; Asproni P; Canale A; Citi S; Poli A
    Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 in neoplasms of the mammary gland in bitches.
    Badowska-Kozakiewicz AM; Malicka E
    Pol J Vet Sci; 2010; 13(2):337-42. PubMed ID: 20731190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines.
    Brunelle M; Sartin EA; Wolfe LG; Sirois J; Doré M
    Vet Pathol; 2006 Sep; 43(5):656-66. PubMed ID: 16966442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 expression in animal cancers.
    Doré M
    Vet Pathol; 2011 Jan; 48(1):254-65. PubMed ID: 20876365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
    Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
    Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic for molecular markers.
    Langsenlehner U; Gerger A; Weitzer W; Krippl P
    Breast Cancer Res Treat; 2007 Jan; 101(2):247. PubMed ID: 16838111
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis.
    Islam MS; Matsumoto M; Hidaka R; Miyoshi N; Yasuda N
    Vet J; 2012 Jun; 192(3):338-44. PubMed ID: 22154426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
    Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.
    Seixas F; Pires MA; Lopes CA
    Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
    Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
    Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary mucinous carcinoma in the cat.
    Sarli G; Brunetti B; Benazzi C
    Vet Pathol; 2006 Sep; 43(5):667-73. PubMed ID: 16966443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 expression in equine tumors.
    Thamm DH; Ehrhart EJ; Charles JB; Elce YA
    Vet Pathol; 2008 Nov; 45(6):825-8. PubMed ID: 18984785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
    Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
    J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.